Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More
November 29, 2022 08:08 ET
|
Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market, by Drug Class, By Cancer Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...
Worldwide Immuno-oncology Industry to 2028 - Featuring Novartis, Merck, Regeneron Pharmaceuticals and Pfizer Among Others
November 16, 2022 04:18 ET
|
Research and Markets
Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro
November 15, 2022 04:00 ET
|
AKAMPION
- Promising data presented at Protein and Antibody Engineering Summit (PEGS) - Multi-functional agent targeting three immune checkpoint receptors - Potential as mono- and combination therapy for...
Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Reports Ltd
August 29, 2022 05:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031: Forecasts by Category (PD1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Cytokines...
Global Checkpoint Inhibitors Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F Featuring AstraZeneca, Bristol-Myers Squibb, Merck & Co, Roche, Pfizer, Incyte, Novartis, and NewLink Genetics
July 29, 2022 06:23 ET
|
Research and Markets
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2022: By Drug, By Application, By End-Users" report has been added to ResearchAndMarkets.com's offering. ...
The Worldwide Metastatic Cancer Drug Industry is Expected to Reach $68.3 Billion by 2028
June 30, 2022 05:33 ET
|
Research and Markets
Dublin, June 30, 2022 (GLOBE NEWSWIRE) -- The "Global Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Cancer Type, Route of Administration, Drug Class,...
Global Immune Checkpoint Inhibitors Market to 2027 - Size, Share & Industry Trends Analysis Report
April 26, 2022 06:43 ET
|
Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma,...
Insights on the Intratumoral Cancer Therapy Global Market to 2027 - by Application, Technology Type, End-users and Region
April 12, 2022 04:43 ET
|
Research and Markets
Dublin, April 12, 2022 (GLOBE NEWSWIRE) -- The "Global Intratumoral Cancer Therapy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis" report has been...
Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Research Inc
April 07, 2022 11:00 ET
|
Visiongain Ltd
Visiongain has published a new report: Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031: Forecasts by Category (PD1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Cytokines Targets,...
Global $140+ Billion Immune Checkpoint Inhibitors Market Opportunity Analysis and Industry Forecasts to 2030
March 29, 2022 05:38 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...